Thursday, 27 October 2022
12 pm CET

Modernize Your Market Landscape Analysis for Faster Decision-Making

In partnership with

Why attend

Competition is increasing and markets are becoming saturated. In the Healthcare and Life Science sectors, developments such as the pandemic and ACA have largely reshaped the environment, creating new threats and opportunities.

Whether you're a large corporation or a fast-growing startup, it's crucial to stay on top of the market changes in real-time. Imagine being the first to uncover business-critical insights and leveraging them to inform your corporate strategy.

Join the live webcast and learn how you can modernize your approach, ditch manual processes, and stay ahead of the curve. Some of the key topics our panel of experts will aim to cover during this session include among others:

• Top Industry trends – The newly emerged and those further accelerated by the pandemic.
• New market access challenges – The post-pandemic, post-ACA era.
• Valuing your competitive set in the marketiplace
• The increasing need for data in decision-making
• Addressing the emergence of non-traditional competitors
• Increase in targeted therapeutics – Has it made the value/ drug benefit case more black and white?
• Drug value evaluation – How have Payor bodies internationally increased scrutiny as part of approval decisions?

The key take-aways

The biggest market research challenges

Four ways to modernize your market landscape analysis

How to automatically identify trends and proactively monitor the market

And many more

The webinar panel

Click to view full speaker details

Aneta Porczynska, Head of Strategy and Operations Oncology Region Europe | NOVARTIS

Director with strong expertise in strategy leadership for Novartis oncology business in Europe, working closely with commercial and finance executives to deliver P&L goals for the region. Leader driving large-scale strategic transformational initiatives, preparing business environment for innovations. Leader of cross-functional and multi-cultural teams, enabling individuals to reach their full potential and grow in the organization. Experience in building high-performing teams.

Clive Whitcher, Executive Vice President - Head of Inceptua Pharma | INCEPTUA GROUP

Clive is an experienced executive leader in the pharmaceutical industry bringing experience from a wide range of therapeutic areas with particular focus on orphan drugs and rare diseases. He has a proven track record of implementing Marketing Authorisation transfer of in-license assets from partners and designing and implementing global commercialisation launch strategies for both in-market assets and launch assets.

Clive is currently the Head of Inceptua Pharma where he is responsible for delivering Inceptua's commercialisation approach for the portfolio and focus on expanding the Pharma group portfolio via new asset evaluation, M&A and in-licensing activities.

Prior to joining Inceptua, Clive was Head of Global Patient Access and Community Engagement at Sobi where he was responsible for the Patient Access Network and designing and implementing Patient Access launch activities, including go-to-market launch pricing, launch sequence development and Health Technology Assessments, which included the launch of the haemophilia portfolio and manging the patient expiry of Orfadin.

Prior to joining Sobi, Clive has significant experience in market access consulting and as a research scientist at the Laboratory of the Government Chemist (LGC).

Clive has a B.Sc. in Biological & Medicinal Chemistry from University of Exeter and a Ph.D. in Advanced Biochemical Engineering from University College London

Craig Farrell, Director, GTM Strategy | ALPHASENSE

Craig Farrell is a senior member of the Go-To-Market Strategy team at AlphaSense. He has been spearheading efforts within both the Life Science vertical, as well as the enterprise search offering of AlphaSense termed Internal Insights. He began his career in a Molecular Cytology research lab at Memorial Sloan Kettering Cancer Center, before moving into the expert network industry at Gerson Lehrman Group in the Healthcare practice. There, he worked across the investment management, private equity, consulting, and corporate client segments to execute primary research with stakeholder engagement throughout the healthcare ecosystem. He also served as a Client Partner a-Connect, before coming back to the expert network industry to serve as Director of Research and Head of Product at Coleman Research Group, where he was a member of the executive management team. Craig received his BA from the University of Pennsylvania.

Download the Webinar

This webinar is in partnership with

AlphaSense

AlphaSense is a market intelligence and search platform used by the world's leading companies and financial institutions. Since 2011, our AI-based technology has helped professionals make smarter business decisions by delivering insights from an extensive universe of public and private content—including company filings, event transcripts, expert call transcripts, news, trade journals, and equity research. Our platform is trusted by over 2,000 enterprise customers, including a majority of the S&P 500. Headquartered in New York City, AlphaSense employs over 650 people across offices in the U.S., U.K., Finland, and India. For more information, please visit www.alpha-sense.com

Learn More

Anchor 1